SipNose
Intranasal Drug-delivery Platform
StartupSipNose is a Yokne'am Illit-based startup in the Health Tech & Life Sciences sector, established in 2011. Intranasal Drug-delivery Platform. SipNose was founded by Daniel Shahaf. The company has 1-10 employees.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageAcquired
- ProductReleased
- ModelB2B
- Employees1-10
- HQYokne'am Illit
- DistrictNorth District
- Last RoundUndisclosed
Daniel ShahafCo-founder & CTO
2 articles covered by sources including en.globes.co.il,
www.businesswire.com.
What does SipNose do?
SipNose focuses on nose-to-brain medical applications and is developing a nasal delivery platform for local, systemic, and central nervous system indications. The company’s intranasal drug-delivery platform uses a mechanism designed to improve efficacy, patient compliance, and safety. SipNose’s noninvasive devices are designed to ensure accurate dose delivery via the nasal cavity and incorporate a simple, efficient mechanism to allow localization of the aerosolized drug in the olfactory epithelium, resulting in better absorption into the olfactory bulb and brain. The company’s technology enables drug molecules of vast chemical and pharmaceutical characteristics to reach the brain faster and more efficiently with higher safety and improved patient experience.
Who founded SipNose?
SipNose was founded in 2011 by Daniel Shahaf (Co-founder & CTO).
What sector is SipNose in?
SipNose operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology, Healthcare, Providers, Patients, Consumers, Demographics & Family, Children, Seniors.
Where is SipNose located?
SipNose is based in 13 Hayetzira St., Yokne'am Illit, Israel, North District.